Brodie Reynolds serves as a Senior Talent Acquisition Partner at Cytokinetics, where he leverages over 17 years of experience in talent acquisition, with a specialized focus on the biotechnology and pharmaceutical sectors. In this pivotal role, Brodie leads full-cycle recruitment efforts for Clinical Development, encompassing...
Brodie Reynolds serves as a Senior Talent Acquisition Partner at Cytokinetics, where he leverages over 17 years of experience in talent acquisition, with a specialized focus on the biotechnology and pharmaceutical sectors. In this pivotal role, Brodie leads full-cycle recruitment efforts for Clinical Development, encompassing Clinical Operations and Biometrics. His expertise in strategic sourcing and market analysis allows him to identify and attract top-tier talent who are not only skilled but also aligned with Cytokinetics’ mission of advancing innovative therapies that improve patient outcomes.
Brodie is particularly passionate about fostering diversity, equity, and inclusion (DEI) within the workforce. He actively partners with internal stakeholders to support DEI initiatives and develop university programs that create pathways for underrepresented talent in the biotech industry. His commitment to these initiatives reflects a broader understanding of how diverse teams drive innovation and enhance organizational performance.
In addition to his recruitment acumen, Brodie excels in creative problem-solving and organizational strategy, enabling him to navigate the complexities of the talent landscape effectively. His strong communication skills and experience in retained search further enhance his ability to build relationships with candidates and hiring managers alike. At Cytokinetics, Brodie is not just filling positions; he is shaping the future of the organization by ensuring that the right talent is in place to support its groundbreaking work in drug development. Through his strategic planning and engagement with social media, he continues to elevate the company’s brand as an employer of choice in the competitive biotech arena.
